FIELD: medicine.
SUBSTANCE: it is offered to apply xenon dissolved in sea-buckthorn oil for correction of organism lesions associated with antioxidant status disorders, and xenon and sea-buckthorn oil based composition. Revealed is potentiating antioxidant effect for xenon dissolved in sea-buckthorn oil due to preserved high level of α-tocopherol.
EFFECT: higher antioxidant effect.
2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF XENON FOR RETENTION OF ANTIOXIDANT PROPERTIES OF SEA-BUCKTHORN OIL | 2006 |
|
RU2325188C1 |
| ANTIOXIDANT FOR COSMETIC AGENTS AND COSMETIC AGENTS | 2007 |
|
RU2362540C1 |
| METHOD FOR IMPROVING TRANSDERMAL PERMEABILITY OF THERAPEUTIC OR COSMETIC TOPICAL PREPARATIONS, METHOD FOR DERMAL ADMINISTRATION OF LIQUID XENON | 2012 |
|
RU2506944C1 |
| COMPOSITION AND METHOD FOR TREATMENT OF FETOPLACENTAL INSUFFICIENCY | 2006 |
|
RU2324486C2 |
| BIOLOGICALLY ACTIVE DAIRY PRODUCT | 2007 |
|
RU2341095C1 |
| PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN VASCULAR COMPLICATIONS OF ALLOXAN DIABETES IN EXPERIMENT | 2010 |
|
RU2455702C1 |
| AGENT FOR EARLY PATHOGENETIC THERAPY OF ACUTE RADIATION DISEASE | 2003 |
|
RU2281092C2 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
